Fate Therapeutics, Inc.

FATE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 28, 2026 8-K
S-8 Aug 13, 2026 S-8
10-Q Aug 13, 2026 10-Q
8-K Aug 13, 2026 8-K
4 Aug 5, 2026 4
4 Aug 5, 2026 4
144 Aug 4, 2026
144 Aug 4, 2026
SCHEDULE 13G/A Jul 8, 2026
4 Jun 15, 2026 OWNERSHIP DOCUMENT
4 Jun 15, 2026 OWNERSHIP DOCUMENT
4 Jun 15, 2026 4
4 Jun 15, 2026 4
4 Jun 15, 2026 4
4 Jun 15, 2026 4
4 Jun 15, 2026 4
4 Jun 15, 2026 4
4 Jun 15, 2026 4
3 Jun 15, 2026 3
8-K Jun 15, 2026 8-K
8-K Jun 4, 2026 8-K
4 May 21, 2026 4
4 May 21, 2026 4
144 May 20, 2026
144 May 20, 2026
← Newer Page 1 of 34 · 848 filings Older →